Mydecine Innovations Group Inc.
Mydecine Innovations Group Inc.
Liste d'échange:
CSEStatut:
Active
Industrie:
Diversified IndustriesSymbole:
MYCOAssociated Securities:
Mydecine Innovations Group Inc. 12FEB2024 WarrantsIndice CSE:
NoDevise:
CAD Mydecine Innovations Group Inc. is a publicly traded, pre-revenue biopharmaceutical company that began operations in North America and Europe in early 2020. Mydecine was founded to increase physicians' access to serotonin-modulating medicine. Recent research has demonstrated the therapeutic potential of psychedelic substances such as psilocybin and MDMA for treating intractable conditions such as pain, anxiety, depression, addiction, and PTSD, along with neurodegenerative disorders. Mydecine believes these compounds can be safer, more effective, and more accessible for patients and medical professionals through modern drug chemistry paired with artificial intelligence (AI). Mydecine is developing innovative medications for target indications with high mortality rates that have lacked innovation for decades and are controlled by dominant corporations.
Mydecine Innovations Group Inc. (MYCO)
0.01
0.00 (0.00%)
Mydecine Innovations Group Inc. (MYCO)
*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.
Quantité demandé
2,682,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
1,113,000
Volume
0
Dernier prix
0.01
Écart minimum
variation nette
Clôture précédente
0.01
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
0.02
Bas 52 semaines
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
0
Cours acheteur
0.00
Cours vendeur
0.01
Quantité offerte
27,000
Volume
0
Dernier prix
0.01
Écart minimum
variation nette
Clôture précédente
0.01
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
2,682,000
Cours acheteur
0.005
Cours vendeur
0.01
Quantité offerte
1,113,000
Volume
0
Dernier prix
0.01
Écart minimum
variation nette
Clôture précédente
0.01
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
0.02
Bas 52 semaines
0.005
*Note: Bid Size and Ask Size fields are displayed as actual quantities
Quantité demandé
0
Cours acheteur
0.00
Cours vendeur
0.01
Quantité offerte
27,000
Volume
0
Dernier prix
0.01
Écart minimum
variation nette
Clôture précédente
0.01
Ouverture
0.00
Day High
0.00
Day Low
0.00
Haut 52 semaines
Bas 52 semaines
*Note: Bid Size and Ask Size fields are displayed as actual quantities
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| BMO Nesbitt Burns Inc. | 269,000 | 0.005 | 0.01 | 97,000 | RBC Capital Markets |
| Desjardins Securities Inc. | 31,000 | 0.005 | 0.01 | 1,000 | Desjardins Securities Inc. |
| CIBC World Markets Inc. | 20,000 | 0.005 | 0.01 | 5,000 | Anonymous |
| Desjardins Securities Inc. | 339,000 | 0.005 | 0.01 | 1,000 | Desjardins Securities Inc. |
| Desjardins Securities Inc. | 20,000 | 0.005 | 0.01 | 4,000 | Desjardins Securities Inc. |
| Questrade Inc. | 10,000 | 0.005 | 0.01 | 81,000 | Desjardins Securities Inc. |
| RBC Capital Markets | 24,000 | 0.005 | 0.01 | 18,000 | National Bank Financial Inc. |
| RBC Capital Markets | 100,000 | 0.005 | 0.01 | 135,000 | Desjardins Securities Inc. |
| BMO Nesbitt Burns Inc. | 200,000 | 0.005 | 0.01 | 29,000 | National Bank Financial Inc. |
| TD Securities Inc. | 314,000 | 0.005 | 0.01 | 20,000 | Anonymous |
| Courtier Bid | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Demandez Broker |
|---|---|---|---|---|---|
| 0 | 0.00 | 0.01 | 27,000 | Anonymous | |
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 | ||
| 0 | 0.00 | 0.00 | 0 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 29 | 2,682,000 | 0.005 | 0.01 | 1,113,000 | 27 |
| 0 | 0 | 0.00 | 0.015 | 328,000 | 13 |
| 0 | 0 | 0.00 | 0.02 | 581,000 | 8 |
| 0 | 0 | 0.00 | 0.025 | 651,000 | 8 |
| 0 | 0 | 0.00 | 0.03 | 100,000 | 1 |
| Acheteur | Quantité demandé | Cours acheteur | Cours vendeur | Quantité offerte | Vendeur |
|---|---|---|---|---|---|
| 0 | 0 | 0.00 | 0.01 | 27,000 | 1 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| 0 | 0 | 0.00 | 0.00 | 0 | 0 |
| Date/Heure | Prix | Modifier | Volume | Acheteur | Vendeur | Venue |
|---|---|---|---|---|---|---|
| Apr 24, 17:50 | 0.01 | 0.00 | 25,000 | National Bank Financial Inc. | National Bank Financial Inc. | CSE |
| Apr 24, 13:30 | 0.005 | -0.005 | 11,000 | BMO Nesbitt Burns Inc. | National Bank Financial Inc. | CSE |
| Apr 24, 13:30 | 0.005 | -0.005 | 4,000 | TD Securities Inc. | TD Securities Inc. | CSE |
| Apr 24, 13:30 | 0.005 | -0.005 | 11,000 | RBC Capital Markets | National Bank Financial Inc. | CSE |
| Apr 23, 13:30 | 0.005 | -0.005 | 1,000 | RBC Capital Markets | National Bank Financial Inc. | CSE |
Information d'entreprise
Addresse
1890 – 1075 West Georgia Street
Vancouver, BC V6E 3C9
CanadaTéléphone
604-687-2038Courriel
hello@mydecineinc.comURL
http://www.mydecineinc.comDate d’inscription à la cote
Vendredi, octobre 6, 2023
Agent de transfert
Endeavor Trust CorporationVérificateur
HDCPA Professional CorporationSEDAR Information
Type de dossier
Tout
Management's Discussion & Analysis
Financial Statements
News Releases
Material Change Report
Délai
@count semaine@count mois3 month6 month@count annéeTout le temps
Information d'entreprise
Addresse
1890 – 1075 West Georgia Street
Vancouver, BC V6E 3C9
CanadaTéléphone
604-687-2038Courriel
hello@mydecineinc.comURL
http://www.mydecineinc.comDate d’inscription à la cote
Vendredi, octobre 6, 2023
Agent de transfert
Endeavor Trust CorporationVérificateur
HDCPA Professional CorporationCapitalisation
Capitalisation:
61755385Réservé à l'émission:
2861428Company Officers
David Joshua Bartch, President and Chief Executive Officer
John Ross, Chief Financial Officer and Corporate Secretary
Damon Michaels , Chief Operations Officer
Robert Roscow, Chief Science Officer
Rakesh Jetly, Chief Medical Officer
Jim Gunning, Chief Marketing Officer
Communiqués de presse
